
Dr Nicola Smith
Fields of research: Receptors and Membrane Biology, Basic Pharmacology, Cardiology (incl. Cardiovascular Diseases)
Contact Details
Phone: +61 2 (0) 9385 1472
Email: nicola.smith@unsw.edu.au
Tabs
Publications related to this Person
Book Chapters
So SS; Ngo T; Keov P; Smith NJ; Kufareva I, 2019, 'Tackling the complexities of orphan GPCR ligand discovery with rationally assisted approaches', in Jastrzebska B; Park PSH (ed.), GPCRs: Structure, Function, and Drug Discovery, ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD, pp. 295 - 334, http://dx.doi.org/10.1016/B978-0-12-816228-6.00016-7
Journal articles
Smith NJ; Grant JN; Moon JI; So SS; Finch AM, 2021, 'Critically evaluating sweet taste receptor expression and signaling through a molecular pharmacology lens.', FEBS J, http://dx.doi.org/10.1111/febs.15768
Nicks AM; Kesteven SH; Li M; Wu J; Chan AY; Naqvi N; Husain A; Feneley MP; Smith NJ; Iismaa SE; Graham RM, 2020, 'Pressure overload by suprarenal aortic constriction in mice leads to left ventricular hypertrophy without c-Kit expression in cardiomyocytes', Scientific Reports, vol. 10, pp. 15318, http://dx.doi.org/10.1038/s41598-020-72273-3
Coleman JLJ; Ngo T; Smythe RE; Cleave AJ; Jones NM; Graham RM; Smith NJ, 2020, 'The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases', Scientific Reports, vol. 10, http://dx.doi.org/10.1038/s41598-020-76384-9
Coleman J; Ngo T; Smythe R; Cleave A; Jones N; Graham R; Smith N, 2020, 'The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases', , http://dx.doi.org/10.1101/2020.06.27.174847
Coleman JLJ; Ngo T; Smith NJ, 2020, 'Corrigendum to “The G protein-coupled receptor N-terminus and receptor signalling: N-tering a new era” [Cellular Signalling 2017 May;33:1–9](S0898656817300451)(10.1016/j.cellsig.2017.02.004)', Cellular Signalling, vol. 68, http://dx.doi.org/10.1016/j.cellsig.2019.109510
Ng CA; Perry MD; Liang W; Smith NJ; Foo B; Shrier A; Lukacs GL; Hill AP; Vandenberg JI, 2020, 'High-throughput phenotyping of heteromeric human ether-à-go-go-related gene potassium channel variants can discriminate pathogenic from rare benign variants', Heart Rhythm, vol. 17, pp. 492 - 500, http://dx.doi.org/10.1016/j.hrthm.2019.09.020
Coleman JLJ; Ngo T; Schmidt J; Mrad N; Liew CK; Jones NM; Graham RM; Smith NJ, 2019, 'Retraction: Metalloprotease cleavage of the N terminus of the orphan G protein-coupled receptor GPR37L1 reduces its constitutive activity (Science Signaling (2016) 9 (ra36) DOI: 10.1126/scisignal.aad1089)', Science Signaling, vol. 12, http://dx.doi.org/10.1126/scisignal.aba2063
Montgomery MK; Osborne B; Brandon AE; O'Reilly L; Fiveash CE; Brown SHJ; Wilkins BP; Samsudeen A; Yu J; Devanapalli B; Hertzog A; Tolun AA; Kavanagh T; Cooper AA; Mitchell TW; Biden TJ; Smith NJ; Cooney GJ; Turner N, 2019, 'Regulation of mitochondrial metabolism in murine skeletal muscle by the medium-chain fatty acid receptor Gpr84', FASEB Journal, vol. 33, pp. 12264 - 12276, http://dx.doi.org/10.1096/fj.201900234R
Sobti M; Ishmukhametov R; Bouwer JC; Ayer A; Suarna C; Smith NJ; Christie M; Stocker R; Duncan TM; Stewart AG, 2019, 'Cryo-EM reveals distinct conformations of E. coli ATP synthase on exposure to ATP', eLife, vol. 8, http://dx.doi.org/10.7554/eLife.43864
Mouat MA; Coleman JLJ; Smith NJ, 2018, 'GPCRs in context: sexual dimorphism in the cardiovascular system', British Journal of Pharmacology, vol. 175, pp. 4047 - 4059, http://dx.doi.org/10.1111/bph.14160
Coleman JLJ; Mouat MA; Wu J; Jancovski N; Bassi JK; Chan AY; Humphreys DT; Mrad N; Yu ZY; Ngo T; Iismaa S; Dos Remedios CG; Feneley MP; Allen AM; Graham RM; Smith NJ, 2018, 'Orphan receptor GPR37L1 contributes to the sexual dimorphism of central cardiovascular control', Biology of Sex Differences, vol. 9, http://dx.doi.org/10.1186/s13293-018-0173-y
Wirasinha RC; Vijayan D; Smith NJ; Parnell GP; Swarbrick A; Brink R; King C; Stewart G; Booth DR; Batten M, 2018, 'GPR65 inhibits experimental autoimmune encephalomyelitis through CD4+ T cell independent mechanisms that include effects on iNKT cells', Immunology and Cell Biology, vol. 96, pp. 128 - 136, http://dx.doi.org/10.1111/imcb.1031
Coleman JLJ; Ngo T; Smith NJ, 2017, 'The G protein-coupled receptor N-terminus and receptor signalling: N-tering a new era', Cellular Signalling, vol. 33, pp. 1 - 9, http://dx.doi.org/10.1016/j.cellsig.2017.02.004
Ngo T; Ilatovskiy AV; Stewart AG; Coleman JLJ; McRobb FM; Riek RP; Graham RM; Abagyan R; Kufareva I; Smith NJ, 2017, 'Orphan receptor ligand discovery by pickpocketing pharmacological neighbors', Nature Chemical Biology, vol. 13, pp. 235 - 242, http://dx.doi.org/10.1038/nchembio.2266
Soetanto R; Hynes CJ; Patel HR; Humphreys DT; Evers M; Duan G; Parker BJ; Archer SK; Clancy JL; Graham RM; Beilharz TH; Smith NJ; Preiss T, 2016, 'Role of miRNAs and alternative mRNA 3'-end cleavage and polyadenylation of their mRNA targets in cardiomyocyte hypertrophy', Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, vol. 1859, pp. 744 - 756, http://dx.doi.org/10.1016/j.bbagrm.2016.03.010
McNamara JW; Li A; Smith NJ; Lal S; Graham RM; Kooiker KB; van Dijk SJ; Remedios CGD; Harris SP; Cooke R, 2016, 'Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes', Journal of Molecular and Cellular Cardiology, vol. 94, pp. 65 - 71, http://dx.doi.org/10.1016/j.yjmcc.2016.03.009
Chowdhury MKH; Wu LE; Coleman JLJ; Smith NJ; Morris MJ; Shepherd PR; Smith GC, 2016, 'Niclosamide blocks glucagon phosphorylation of Ser552 on β-catenin in primary rat hepatocytes via PKA signalling', Biochemical Journal, vol. 473, pp. 1247 - 1255, http://dx.doi.org/10.1042/BCJ20160121
Coleman JLJ; Ngo T; Schmidt J; Mrad N; Liew CK; Jones NM; Graham RM; Smith NJ, 2016, 'Metalloprotease cleavage of the N terminus of the orphan G protein-coupled receptor GPR37L1 reduces its constitutive activity', Science Signaling, vol. 9, http://dx.doi.org/10.1126/scisignal.aad1089
Grundmann M; Tikhonova IG; Hudson BD; Smith NJ; Mohr K; Ulven T; Milligan G; Kenakin T; Kostenis E, 2016, 'A Molecular Mechanism for Sequential Activation of a G Protein-Coupled Receptor', Cell Chemical Biology, vol. 23, pp. 392 - 403, http://dx.doi.org/10.1016/j.chembiol.2016.02.014
Ngo T; Kufareva I; Coleman JLJ; Graham RM; Abagyan R; Smith NJ, 2016, 'Identifying ligands at orphan GPCRs: current status using structure-based approaches', British Journal of Pharmacology, vol. 173, pp. 2934 - 2951, http://dx.doi.org/10.1111/bph.13452
Foster SR; Porrello ER; Stefani M; Smith NJ; Molenaar P; Dos Remedios CG; Thomas WG; Ramialison M, 2015, 'Cardiac gene expression data and in silico analysis provide novel insights into human and mouse taste receptor gene regulation', Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 388, pp. 1009 - 1027, http://dx.doi.org/10.1007/s00210-015-1118-1
Coleman JLJ; Brennan K; Ngo T; Balaji P; Graham RM; Smith NJ, 2015, 'Rapid knockout and reporter mouse line generation and breeding colony establishment using EUCOMM conditional-ready embryonic stem cells: A case study', Frontiers in Endocrinology, vol. 6, http://dx.doi.org/10.3389/fendo.2015.00105
Smith NJ, 2015, 'Drug discovery opportunities at the endothelin B receptor-related orphan g protein-coupled receptors, GPR37 and GPR37L1', Frontiers in Pharmacology, vol. 6, http://dx.doi.org/10.3389/fphar.2015.00275
Ngo T; Coleman JLJ; Smith NJ, 2015, 'Using constitutive activity to defi ne appropriate high-throughput screening assays for orphan G protein-coupled receptors', Methods in Molecular Biology, vol. 1272, pp. 91 - 106, http://dx.doi.org/10.1007/978-1-4939-2336-6_7
Yu ZY; Tan JC; McMahon AC; Iismaa SE; Xiao H; Kesteven SH; Reichelt ME; Mohl MC; Smith NJ; Fatkin D; Allen D; Head SI; Graham RM; Feneley MP, 2014, 'RhoA/ROCK signaling and pleiotropic α
Smith NJ, 2012, 'Low affinity GPCRs for metabolic intermediates: Challenges for pharmacologists', Frontiers in Endocrinology, vol. 3, http://dx.doi.org/10.3389/fendo.2012.00001
Smith NJ; Ward RJ; Stoddart LA; Hudson BD; Kostenis E; Ulven T; Morris JC; Tränkle C; Tikhonova IG; Adams DR; Milligan G, 2011, 'Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator', Molecular Pharmacology, vol. 80, pp. 163 - 173, http://dx.doi.org/10.1124/mol.110.070789
Smith NJ; Chan HW; Qian H; Bourne AM; Hannan KM; Warner FJ; Ritchie RH; Pearson RB; Hannan RD; Thomas WG, 2011, 'Determination of the exact molecular requirements for type 1 angiotensin receptor epidermal growth factor receptor transactivation and cardiomyocyte hypertrophy', Hypertension, vol. 57, pp. 973 - 980, http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.166710
Schmidt J; Smith NJ; Christiansen E; Tikhonova IG; Grundmann M; Hudson BD; Ward RJ; Drewke C; Milligan G; Kostenis E; Ulven T, 2011, 'Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: Identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3', Journal of Biological Chemistry, vol. 286, pp. 10628 - 10640, http://dx.doi.org/10.1074/jbc.M110.210872
Flores-Muñoz M; Smith NJ; Haggerty C; Milligan G; Nicklin SA, 2011, 'Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor', Journal of Physiology, vol. 589, pp. 939 - 951, http://dx.doi.org/10.1113/jphysiol.2010.203075
Smith NJ; Bennett KA; Milligan G, 2011, 'When simple agonism is not enough: Emerging modalities of GPCR ligands', Molecular and Cellular Endocrinology, vol. 331, pp. 241 - 247, http://dx.doi.org/10.1016/j.mce.2010.07.009
Hudson BD; Smith NJ; Milligan G, 2011, 'Experimental Challenges to Targeting Poorly Characterized GPCRs. Uncovering the Therapeutic Potential for Free Fatty Acid Receptors', Advances in Pharmacology, vol. 62, pp. 175 - 218, http://dx.doi.org/10.1016/B978-0-12-385952-5.00006-3
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G, 2010, 'Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate G
Smith NJ; Milligan G, 2010, 'Allostery at G protein-coupled receptor homo- and heteromers: Uncharted pharmacological landscapes', Pharmacological Reviews, vol. 62, pp. 701 - 725, http://dx.doi.org/10.1124/pr.110.002667
Schröder R; Janssen N; Schmidt J; Kebig A; Merten N; Hennen S; Müller A; Blättermann S; Mohr-Andrä M; Zahn S; Wenzel J; Smith NJ; Gomeza J; Drewke C; Milligan G; Mohr K; Kostenis E, 2010, 'Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements', Nature Biotechnology, vol. 28, pp. 943 - 949, http://dx.doi.org/10.1038/nbt.1671
Milligan G; Stoddart LA; Smith NJ, 2009, 'Agonism and allosterism: The pharmacology of the free fatty acid receptors FFA2 and FFA3', British Journal of Pharmacology, vol. 158, pp. 146 - 153, http://dx.doi.org/10.1111/j.1476-5381.2009.00421.x
Smith NJ; Stoddart LA; Devine NM; Jenkins L; Milligan G, 2009, 'The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1', Journal of Biological Chemistry, vol. 284, pp. 17527 - 17539, http://dx.doi.org/10.1074/jbc.M109.012849
Stoddart LA; Smith NJ; Milligan G, 2008, 'International union of pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: Pharmacology and pathophysiological functions', Pharmacological Reviews, vol. 60, pp. 405 - 417, http://dx.doi.org/10.1124/pr.108.00802
Stoddart LA; Smith NJ; Jenkins L; Brown AJ; Milligan G, 2008, 'Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids', Journal of Biological Chemistry, vol. 283, pp. 32913 - 32924, http://dx.doi.org/10.1074/jbc.M805601200
Milligan G; Smith NJ, 2007, 'Allosteric modulation of heterodimeric G-protein-coupled receptors', Trends in Pharmacological Sciences, vol. 28, pp. 615 - 620, http://dx.doi.org/10.1016/j.tips.2007.11.001
Smith NJ; Luttrell LM, 2006, 'Signal switching, crosstalk, and arrestin scaffolds: Novel G protein-coupled receptor signaling in cardiovascular disease', Hypertension, vol. 48, pp. 173 - 179, http://dx.doi.org/10.1161/01.HYP.0000232641.84521.92
Chan HW; Smith NJ; Hannan RD; Thomas WG, 2006, 'Tackling the EGFR in pathological tissue remodelling', Pulmonary Pharmacology and Therapeutics, vol. 19, pp. 74 - 78, http://dx.doi.org/10.1016/j.pupt.2005.04.005
Thomas WG; Qian H; Smith NJ, 2004, 'When 6 is 9: 'Uncoupled' AT
Smith NJ; Chan HW; Osborne JE; Thomas WG; Hannan RD, 2004, 'Hijacking epidermal growth factor receptors by angiotensin II: New possibilities for understanding and treating cardiac hypertrophy', Cellular and Molecular Life Sciences, vol. 61, pp. 2695 - 2703, http://dx.doi.org/10.1007/s00018-004-4244-3
Devlin MG; Smith NJ; Ryan OM; Guida E; Sexton PM; Christopoulos A, 2004, 'Regulation of serotonin 5-HT
Smith NJ; Hannan RD; Thomas WG; Lew RA, 2003, 'AngiotensinII mediates cardiomyocyte hypertrophic growth pathways via MMP-dependent HB-EGF liberation', Letters in Peptide Science, vol. 10, pp. 431 - 435, http://dx.doi.org/10.1007/BF02442574
Ngo T; Wilkins BP; So SS; Keov P; Chahal KK; Finch AM; Coleman JLJ; Kufareva I; Smith NJ, 'Orphan G protein-coupled receptor, GPR37L1: pharmacological toolbox empty once again', , http://dx.doi.org/10.1101/2020.09.11.290486
Conference Papers
Nicks AM; Humphreys DT; Holman SR; Chan AY; Djordjevic D; Naqvi N; Husain A; Smith NJ; Ho JW; Iismaa SE; Graham RM, 2018, 'Transcription Factors Driving Postnatal Cardiomyocyte Maturation', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000528619405230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Coleman JL; Mouat MA; Wu J; Jancovski N; Humphreys DT; Stefani M; Dos Remedios CG; Feneley MP; Allen AM; Graham RM; Smith NJ, 2017, 'Blood Pressure is Increased in Female Mice Lacking Orphan G Protein-Coupled Receptor Gpr37L1', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Pentagon City, VA, presented at Quality of Care and Outcomes Research Scientific Sessions, Pentagon City, VA, 02 April 2017 - 03 April 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000396815605115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Yu Z-Y; Tan J-C; McMahon AC; Lismaa SF; Xiao X-H; Kesteven SH; Reichelt ME; Mohl MC; Dai Y; Sketchley AE; Yanq LL; Gong H; Smith NJ; Fatkin D; Allen D; Head SI; Graham RM; Feneley MP, 2013, 'Critical Role of RhoA/ROCK Signaling in Cardiac Contractility', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Dallas, TX, presented at Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association, Dallas, TX, 16 November 2013 - 17 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000332162903138&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Smith NJ; Schmidt J; Mrad N; Coleman JL; Hynes CJ; Wu J; Stefani M; Yu Z-Y; Liew CK; dos Remedios C; Graham RM, 2013, 'N-Terminal Processing of an Orphan GPCR: A Novel Mechanistic Target for the Treatment of Cardiovascular Disease?', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Dallas, TX, presented at Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association, Dallas, TX, 16 November 2013 - 17 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000332162903173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Flores-Munoz M; Smith NJ; Haggerty C; Thomas WG; Baker AH; Milligan G; Nicklin SA, 2010, 'Angiotensin1-9 Antagonises Cardiomyocyte Hypertrophy via the Angiotensin Type 2 Receptor', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Washington, DC, pp. E130 - E131, presented at High Blood Pressure Research Scientific Sessions 2010, Washington, DC, 13 October 2010 - 16 October 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283240400362&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Chan HW; Jenkins A; Pipolo L; Hannan RD; Thomas WG; Smith NJ, 2006, 'Effect of dominant-negative epidermal growth factor receptors on cardiomyocyte hypertrophy', in Journal of Receptors and Signal Transduction, pp. 659 - 677, http://dx.doi.org/10.1080/10799890600923187
Chan H-W; Jenkins A; Pipolo L; Hannan RD; Thomas WG; Smith NJ, 2006, 'Effect of dominant-negative epidermal growth factor receptors on cardiomyocyte hypertrophy', in JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, TAYLOR & FRANCIS LTD, Univ Basel, Pharmacenter, Basel, SWITZERLAND, pp. 659 - 677, presented at 10th Swiss Receptor Workshop, Univ Basel, Pharmacenter, Basel, SWITZERLAND, 12 March 2006 - 15 March 2006, http://dx.doi.org/10.1080/10799890600923187
Conference Abstracts
Montgomery MK; Brandon AE; O'Reilly L; Osborne B; Fiveash CE; Brown SH; Smith NJ; Mitchell TW; Biden TJ; Cooney GJ; Turner N, 2016, 'The free fatty acid receptor GPR84: A new player in glucose tolerance and mitochondrial function?', in DIABETOLOGIA, SPRINGER, Munich, GERMANY, Vol. 59, pp. S322 - S322, presented at 52nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Munich, GERMANY, 12 September 2016 - 16 September 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398373702048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Foster SR; Porrello ER; Stefani M; Smith NJ; Molenaar P; dos Remedios CG; Thomas WG; Ramialison M, 2014, 'Transcriptional Regulation of Taste Receptor Genes: Novel Insights From In Silico and Cardiac Gene Expression Analyses', in CHEMICAL SENSES, OXFORD UNIV PRESS, Brisbane, AUSTRALIA, Vol. 40, pp. 366 - 367, presented at 15th Scientific Meeting of the Australasian-Association-for-ChemoSensory-Science (AACSS), Brisbane, AUSTRALIA, 03 December 2014 - 05 December 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357868900036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Nicks AM; Li M; Wu J; Kesteven SH; Fenely MP; Smith NJ; Iismaa SE; Graham RM, 2014, 'A SURGICAL MODEL OF HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY IN MICE BY SUPRARENAL AORTIC CONSTRICTION', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Adelaide, AUSTRALIA, Vol. 65, pp. E39 - E39, presented at 36th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA), Adelaide, AUSTRALIA, 26 November 2014 - 28 November 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352490400055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Please contact SoMS Admin soms.info@unsw.edu.au to be added to our mail list. New SoMS staff and students are required to complete the SoMS webform as part of the data management procedure in the School.
School of Medical Sciences - Wallace Wurth Building, UNSW Sydney NSW 2052 Australia | Contacts
© Copyright 2012 UNSW Medicine | CRICOS Provider Code: 00098G | ABN 57 195 873 179 | Authorised by Head of School of Medical Sciences